Joakim Wijkstrom
SVP, Chief Marketing Officer, Vanda Pharmaceuticals Inc.
Companies
- Vanda Pharmaceuticals Inc.SVP, Chief Marketing Officer Aug 21, 2019 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Vanda Pharmaceuticals Inc. VNDA333,469 shares2$1.4M at $4.24Mar 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 2, 2026Sold 30,800 shares at $8.27 of Vanda Pharmaceuticals Inc.2
- Feb 18, 2026Granted 125,000 shares of Vanda Pharmaceuticals Inc.3
- Mar 1, 2025Shares withheld for tax 15,520 shares at $4.76 of Vanda Pharmaceuticals Inc.4
- Feb 18, 2025Granted 125,000 shares of Vanda Pharmaceuticals Inc.5
- Mar 5, 2024Sold 9,229 shares at $4.21 of Vanda Pharmaceuticals Inc.6
- Mar 4, 2024Sold 7,498 shares at $4.41 of Vanda Pharmaceuticals Inc.6
- Feb 16, 2024Granted 32,700 shares of Vanda Pharmaceuticals Inc.7
- Aug 21, 2023Sold 3,724 shares at $5.84 of Vanda Pharmaceuticals Inc.8
- Mar 3, 2023Sold 4,113 shares at $6.32 of Vanda Pharmaceuticals Inc.9
- Mar 2, 2023Sold 7,720 shares at $6.23 of Vanda Pharmaceuticals Inc.9
- Feb 16, 2023Granted 32,700 shares of Vanda Pharmaceuticals Inc.10
- Aug 22, 2022Sold 3,605 shares at $10.27 of Vanda Pharmaceuticals Inc.11
- Mar 2, 2022Sold 6,974 shares at $11.19 of Vanda Pharmaceuticals Inc.12
- Feb 28, 2022Granted 32,700 shares of Vanda Pharmaceuticals Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 19, 2026
- 4SEC EDGARForm 4 filed Mar 4, 2025
- 5SEC EDGARForm 4 filed Feb 20, 2025
- 6SEC EDGARForm 4 filed Mar 6, 2024
- 7SEC EDGARForm 4 filed Feb 21, 2024
- 8SEC EDGARForm 4 filed Aug 23, 2023
- 9SEC EDGARForm 4 filed Mar 6, 2023
- 10SEC EDGARForm 4 filed Feb 21, 2023
- 11SEC EDGARForm 4 filed Aug 23, 2022
- 12SEC EDGARForm 4 filed Mar 2, 2022